Visit us at TCT '09 booth# 622

Come to our InspireMD Breakfast Meeting

The Role of the MGuard™ Stent in Thrombus Management during AMI Interventions

Chairman: Martin Leon, MD

Panel:  Alexandre Abizaid, MD PhD, Antonio Colombo, MD, Peter J. Fitzgerald, MD, PhD, Jacek Legutko, MD, PhD, Chaim Lotan, MD, Christian M. Spaulding, MD, PhD

6 Month MAGICAL STEMI Trial Results (D. Dudek)

Time and Location: Thursday, Sept. 24th at 07:00am

Moscone Convention Center: Room 132 

Visit us at TCTAP '09 booth# C16, Exhibition Room 2

InspireMD is delighted to present MGuard™:

-An innovative stent system designed for acute coronary syndromes.

See Us Also At PCR 2009, Barcelona, Spain. May 19-22 Booth# F12

Coming Up At PCR 2009:

-MAGICAL Trial Results (STEMI Study Final Results Of Primary Endpoint

-FIM, One Year Follow-Up

-GUARD Study (Interim 30 Days Results With IVUS Analysis

InspireMD celebrated much success at TCT 2008, Washington DC, USA. October 12-16, Booth #1411

-Meeting Chairman: Martin Leon MD

-WHEN: 7:00-8:00am, Thursday October 16

-WHERE: Room 143C, Washington Convention Center

BREAKFAST MEETING October 16th - TCT 2008

Meeting Topic: A New Approach to Treating Thrombus - Containing Lesions (SVG, AMI, and ACS)

-Meeting Chairman: Martin Leon MD

-WHEN: 7:00-8:00am, Thursday October 16

-WHERE: Room 143C, Washington Convention Center

InspireMD has the pleasure to invite you to the InspireMD Breakfast Meeting at TCT 2008.

This represents a rare opportunity for you to attend a meeting that will discuss the latest clinical data regarding the break

Key world renowned interventional cardiologists will lead the session and you will come away with a deep understanding as to how important the MGuard stent will be as a pioneering technology for the treatment of thrombus containing lesions.

Speakers: Alexandre Abizaid MD, Antonio Colombo MD, Gian-Battista Danzi MD, Dariusz Dudek MD, Eberhard Grube MD, Martin Leon, MD, Chaim Lotan MD, Carlo Di Mario MD, Gregory Pavlides MD.

Visit Us At ACC 2009, Orlando, FL, USA, March 29-31, Booth #3567

NEW Intriquing Clinical Results at ACC 09. Dr. Alexandre Abizaid. Sunday, March 29t  h at 5:30PM-5:42PM (Room W414D)

The “MGuard First in Man Trial - 30 Days’ Results.”  Abstract

This abstract has been accepted for TCT 2008 as a poster. You may be able to view it as abstract number “484." where a full abstract will be available for view at TCT. To date, very promising 30 day and six months results have proven safety and efficacy of the MGuard.

MGuard is not available for sale in the United State